METROPOLISBSEMETROPOLIS HEALTHCARE LTDMediumNeutral
Announced Mon, 27 Jul · 20:24 IST

Annual Report FY26 and AGM notice filed with BSE and NSE

Board & Shareholder Meetings View source PDF

METROPOLIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
₹582.00
prior close
₹582.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.2+0.9+0.8
Up moveDown movePending
AI summary

Metropolis Healthcare filed its FY26 Annual Report along with the 26th AGM notice, scheduled for August 18, 2026 via video conferencing. FY26 highlights: group revenue grew 23.6 percent to Rs 1,646 crore, EBITDA rose 32 percent to Rs 401 crore, and PAT increased 31 percent to Rs 191 crore. Organic revenue grew 13.7 percent, beating 12-13 percent guidance. The company served 14 million patients and 30 million tests across 5,000 plus service touchpoints and 210 plus labs. Bonus shares were issued in 3:1 ratio in March 2026. Specialty diagnostics and TruHealth both delivered strong double-digit growth.

Likely market impact

Routine annual filing with AGM notice for August 18. Strong FY26 results show margin recovery, specialty growth, and successful acquisition integration.